LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

Начало・Списък с акции・Haemonetics Corp

Haemonetics Corp

Затворен

СекторЗдравеопазване

70.26 1.37

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

68.81

Максимум

70.4

Ключови измерители
By Trading Economics
Приходи	3.7M 37M
Продажби	3M 349M
P/E Средно за сектора	21.218 56.602
EPS	1.24
Марж на печалбата	10.757
EBITDA	-5.7M 90M

Препоръки
By TipRanks
Препоръки	Силна покупка
12-месечна прогноза	+32.96% upside

Дивиденти
By Dow Jones
Следващи печалби	7.08.2025 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	-191M 3.4B
Предишно отваряне	68.89
Предишно затваряне	70.26

Настроения в новините

By Acuity

67%

33%

339 / 382 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Strong Bullish Evidence

62.51 / N/A Подкрепа & съпротива

Haemonetics Corp Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

15.05.2025 г., 22:52 ч. UTC

Печалби

Значими двигатели на пазара

Virgin Galactic Shares Rise on Commercial Spaceflight Plans, Narrower 1Q Loss

15.05.2025 г., 20:37 ч. UTC

Топ новини

Печалби

Applied Materials Logs Higher 2Q Profit, Revenue as Customer Demand Remains Unchanged

16.05.2025 г., 00:00 ч. UTC

Пазарно говорене

Xero Bull Stays Positive on Cost Outlook -- Market Talk

15.05.2025 г., 23:47 ч. UTC

Пазарно говорене

Gold Consolidates; Likely Supported by Signs of Disinflation -- Market Talk

15.05.2025 г., 23:38 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

15.05.2025 г., 23:38 ч. UTC

Пазарно говорене

Nikkei May Edge Higher, Tracking Gains Across Most U.S. Equity Markets -- Market Talk

15.05.2025 г., 23:14 ч. UTC

Топ новини

Walmart Becomes Biggest Retailer Yet to Pass Through Tariff Price Increases -- 4th Update

15.05.2025 г., 22:46 ч. UTC

Топ новини

Придобивния, сливания и поглъщания

Bayer Seeks New Roundup Settlement While Exploring Monsanto Bankruptcy -- WSJ

15.05.2025 г., 22:46 ч. UTC

Придобивния, сливания и поглъщания

Bayer Working With Restructuring Advisers Latham, AlixPartners to Explore Options for Monsanto -- WSJ

15.05.2025 г., 22:46 ч. UTC

Придобивния, сливания и поглъщания

Bayer Exec Says Company Committed to Resolving Roundup Lawsuits in 18 Months -- WSJ

15.05.2025 г., 22:46 ч. UTC

Придобивния, сливания и поглъщания

Bayer Seeks New Roundup Settlement While Exploring Monsanto Bankruptcy -- WSJ

15.05.2025 г., 21:58 ч. UTC

Печалби

Applied Materials Earnings Beat Expectations. Why the Stock Is Down. -- Barrons.com

15.05.2025 г., 21:24 ч. UTC

Печалби

Cava's Earnings Beat Expectations. Growth Was Strong Despite Tariff Fears. -- Barrons.com

15.05.2025 г., 20:56 ч. UTC

Пазарно говорене

U.S. Spending Downturn Could Lie Ahead -- Market Talk

15.05.2025 г., 20:54 ч. UTC

Пазарно говорене

Печалби

Applied Materials CFO Says Demand Stable Despite Tariffs, Macro -- Market Talk

15.05.2025 г., 20:54 ч. UTC

Печалби

Applied Materials Investing to Support Semiconductor Market of More Than $1T by End of Decade, Financial Chief Says

15.05.2025 г., 20:51 ч. UTC

Печалби

Applied Materials Financial Chief: Long-Term Secular Growth Drivers Remain Intact

15.05.2025 г., 20:50 ч. UTC

Пазарно говорене

Financial Services Roundup: Market Talk

15.05.2025 г., 20:50 ч. UTC

Придобивния, сливания и поглъщания

Berkshire Sells Financial Stocks, Doubles Constellation Stake, Holds Steady on Apple -- WSJ

15.05.2025 г., 20:50 ч. UTC

Печалби

Applied Materials' Customer Investments Continue at Expected Rate and Pace, Financial Chief Says

15.05.2025 г., 20:47 ч. UTC

Печалби

Applied Materials Not Currently Seeing Large Changes in Customer Demand, CEO Says

15.05.2025 г., 20:47 ч. UTC

Печалби

Applied Materials Sees Revenue From Advanced DRAM Customers to Grow 40% in FY25, CEO Says

15.05.2025 г., 20:47 ч. UTC

Печалби

Applied Materials Grew Faster Than Peers in Markets Outside China in 2Q, CEO Says

15.05.2025 г., 20:47 ч. UTC

Печалби

Applied Materials Underperformed Market in China in 2Q Due to Restrictions on U.S. Companies, CEO Says

15.05.2025 г., 20:37 ч. UTC

Печалби

SOS Ltd: Growth Was Fueled by Robust Domestic Demand and Expansion of Pdt Portfolio to Include Rubber and Coal >SOS

15.05.2025 г., 20:37 ч. UTC

Печалби

SOS Ltd: Cryptocurrency Mining Rev Declined to $9.3M From $18.9M in FY23, Dip Was Attributed to the Temporary Shutdown of Texas Mining Facility for Upgrades During 1H 2024 >SOS

15.05.2025 г., 20:37 ч. UTC

Печалби

SOS Ltd: FY24 Significant Yr-over-Yr Increase in Commodity Trading Rev, Which Soared to $214.3M FY24, 92.6% of Total Rev Up From 74.0% in FY23 >SOS

15.05.2025 г., 20:37 ч. UTC

Печалби

SOS Ltd: Cryptocurrency Mining Rev Halves as SOS Focuses on Facility Upgrades and Commodity Expansion >SOS

15.05.2025 г., 20:26 ч. UTC

Топ новини

Trump Presses Apple to Bring iPhone Manufacturing to America. Wall Street Shrugs. -- WSJ

15.05.2025 г., 20:25 ч. UTC

Печалби

Deere Stock Jumps on Guidance Cut. Here's Why. -- Barrons.com

Сравнение с други в отрасъла

Ценова промяна

Haemonetics Corp Прогноза

Ценова цел

By TipRanks

32.96% нагоре

12-месечна прогноза

Среден 92.25 USD 32.96%

Висок 105 USD

Нисък 84 USD

Според 4 анализатори от Wall Street, предложили 12-месечна ценова цел за Haemonetics Corp през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

4 ratings

Купи

Задържане

Продай

Според 4 анализатори, дали борсови рейтинги на Haemonetics Corp през последните 3 месеца.

Техническа оценка

By Trading Central

62.51 / N/AПодкрепа & съпротива

All events are bullish.

Recent bullish events outweigh bearish events.

Bearish events outweigh bullish events.

Настроение

By Acuity

339 / 382 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Haemonetics Corp

Haemonetics Corporation, a healthcare company, provides suite of medical products and solutions in the United States and internationally. The company offers automated plasma collection systems, donor management software, and supporting software solutions including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system and Donor360 app. It also provides automated blood component and manual whole blood collection systems, such as MCS brand apheresis equipment to collect specific blood components from the donor; disposable whole blood collection and component storage sets; SafeTrace Tx blood bank information system; and BloodTrack blood management software, a suite of blood management and bedside transfusion solutions that combines software with hardware components, as well as an extension of the hospital's blood bank information system. In addition, the company offers hospital products comprising TEG and HAS hemostasis analyzer systems that provide a comprehensive assessment of a patient's overall hemostasis; and TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions. Further, it provides Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries; and VASCADE products comprising VASCADE and VASCADE MVP, a technology platform which offers catheter-based delivery system and leverages the natural clot-inducing properties of collagen. The company sells its products through direct sales force, independent distributors, and sales representatives. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts.